/
/
/

Astonea Labs Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---51%
----16%
---113%
21%21%21%12%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
ASTONEALAB-M
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,792.65₹425150 Cr38.778.2958.23₹11479 Cr
10,005₹266265 Cr91.0334.04128.41₹2568 Cr
4,682.45₹176301 Cr8314.04106.21₹2163 Cr
2,320.75₹125352 Cr93.568.1733.94₹889 Cr
1,193.75₹123591 Cr27.399.4262.53₹5040 Cr
1,365.55₹114351 Cr40.8411.0859.2₹4196 Cr
1,389.7₹112474 Cr38.8210.8652.6₹3879 Cr
2,482.6₹102315 Cr45.6217.2376.26₹1913 Cr
1,710₹97757 Cr26.3317.9596.84₹3505 Cr
2,027₹92007 Cr16.6430.95154.35₹5333 Cr
335₹347 Cr76.822.959.04₹5 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025
——
₹11 Cr₹8 Cr
₹47 Cr₹11 Cr
₹47 Cr₹11 Cr
₹57 Cr₹18 Cr
₹18 Cr₹16 Cr
₹3 Cr₹4 Cr
-₹55 L₹3 L
₹8 L₹0
₹43 L₹33 L
₹21 Cr₹20 Cr
——
₹40 Cr₹26 Cr
₹8 Cr₹8 Cr
₹19 Cr₹29 Cr
₹2 Cr₹2 Cr
₹69 Cr₹65 Cr
₹147 Cr₹104 Cr
₹4 Cr₹9 Cr
₹43 Cr₹53 Cr
——
₹31 Cr₹26 Cr
₹31 Cr₹26 Cr
₹8 Cr₹4 Cr
₹6 Cr₹0
₹6 Cr₹0
₹30 L₹29 L
₹2 Cr₹2 Cr
₹48 Cr₹33 Cr
——
₹34 Cr₹29 Cr
₹52 Cr₹38 Cr
₹18 L₹9 L
₹84 L₹33 L
₹13 Cr₹4 Cr
₹100 Cr₹71 Cr
₹30 Cr₹6 Cr
₹147 Cr₹104 Cr
₹54₹24
₹54₹24

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025
₹6 Cr₹7 Cr
₹8 Cr₹8 Cr
-₹24 Cr-₹2 Cr
-₹10 Cr₹13 Cr
-₹14 Cr₹9 Cr
-₹20 Cr-₹11 Cr
₹34 Cr₹2 Cr
₹9 L-₹27 L
₹9 L₹36 L
₹18 L₹9 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)335.00
Volume (₹)1,000.00
High (₹)335.00
Upper Circuit363.00
Low (₹)335.00
Lower Circuit297.00
Prev Close330.00
52W High (₹)369.00
Price335.00
52W Low (₹)118.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)346.86 Cr
Div. Yield (%)0.00
PE Ratio76.82
Debt to Equity0.75
Price to Book2.82
Book Value54.35
EPS (TTM)4.30
Face Value10.00
ROE (%)11.95

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
ASTONEALAB-MNSE
LTP
1W Low
1W High
Market cap (₹)
1792.65+14.4 (0.81%)
1720.80
1809.65
4,25,150Cr
10005+290 (2.99%)
9866.35
10080.20
2,66,265Cr
4682.45+47.3 (1.02%)
4555
4695
1,76,301Cr
2320.75-71.25 (-2.98%)
2252.50
2442
1,25,352Cr
1193.75-50.25 (-4.04%)
1189
1266.15
1,23,591Cr
1365.55+15.35 (1.14%)
1337.30
1390.70
1,14,351Cr
1389.7+9.7 (0.70%)
1364.75
1400.60
1,12,474Cr
2482.6-6.15 (-0.25%)
2457.35
2523.70
1,02,315Cr
1710+32.2 (1.92%)
1656.90
1714
97,757Cr
2027+18 (0.90%)
1989.10
2061.55
92,007Cr
335-5 (-1.47%)
330
340
347Cr

Astonea Labs Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Astonea Labs Ltd Quaterly Results Key Takeaways